Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism NOX inhibitors(NADPH oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Phase 2 | South Korea | 15 Jun 2020 | |
Arteriosclerosis | Preclinical | South Korea | 01 Jan 2025 |